Supernus Pharmaceuticals Reports Strong Q2 2024 Growth
Supernus Pharmaceuticals sees a 24% YoY revenue increase in Q2 2024, driven by key drugs Qelbree and GOCOVRI.
- Latest
- Trending
Supernus Pharmaceuticals sees a 24% YoY revenue increase in Q2 2024, driven by key drugs Qelbree and GOCOVRI.
Join us as we explore China's XR ecosystem from August 29 to September 23, visiting Guangzhou, Shenzhen, Hangzhou, Qingdao, and ...
Bitcoin climbed 1.8% to $56,829, while Solana surged 7% to $151. Mixed trends observed with some tokens rising and others ...
Ethereum, Bitcoin, and Ripple show recovery as ETH aims for $2,803, BTC metrics improve, and XRP crosses $0.5000.
Ethereum sees a 7.31% price increase to $2,458.93 today, showing strong recovery from its 52-week low. Explore its market impact ...
Bitcoin rebounds above $56K with a broad market recovery; Solana leads gains. Japan's Topix and major indexes recover amid Fed ...
"Bitcoin stays under $62K as Notcoin leads gains with a 14% surge. Market cap up by 0.87%. Get the latest ...
XRP shows bullish signs, recovering from a $0.4620 low. Key resistance at $0.4825 could lead to gains. Downside risks if ...
Altcoins like SHIB, DOGE, XRP, RBLK, and AVAX may outperform Bitcoin as altseason nears, with Rollblock (RBLK) set to excel ...
Crypto Market Update: Bitcoin dips below $62k as downtrend continues; ETH, DOGE, and SOL show mixed performances; Fetch.ai leads gains, ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.